Big Data: a new therapeutic option? Part 5: The future of pharma
What is the future for the pharmaceutical industry? Following Part 4: Predict or cure? 5) What future for the pharmaceutical industry? This paradigm shift is also one of the ways forward for a pharmaceutical industry whose historical model is undergoing a crisis. Calico (Google) is tackling the challenge of “age and associated diseases” by recruiting […]
Big Data: a new therapeutic option? Part 4: Predict or cure?
Personalized medicine. Predict or cure: do we need to choose? Following Part 3: Data as raw material 4) Personalized medicine: predict or cure – should we choose? Even if it is often written that “personalized medicine is already a reality in some cases“, or that “personalized medicine is within reach“, it is justified to wonder […]
Big Data: a new therapeutic option? Part 3: Data as raw material
Data as an inexhaustible resource, the expert’s raw material Following Part 2: The end of averaging 3) Data: an inexhaustible resource – the expert’s raw material Whether they are in massive amounts, of reduced volume, or of intermediate size, data are always generated with a precise objective (they are then characterised as primary data). They […]
Big Data: a new therapeutic option? Part 2: The end of averaging
All similar, yet so different: the end of averaging Following Part 1: Know thyself 2) All different and yet so similar – the end of “averaging” We are all different from one other. “Each patient is unique” as doctors often say. Each of us is indeed a unique combination of a multitude of genetic, biological, […]
Big Data: a new therapeutic option? Part 1: Know thyself
Does quantified self mean knowing thyself? Would data have therapeutic virtues? Could “Big Data” be a weapon of mass healing? The idea is less absurd than one might think at first glance. The placebo effect is the best illustration thereof: the simple fact of being informed that one is receiving a treatment (regardless of the […]
